The Diagnostic and Prognostic Value of Speckle Tracking Imaging in Septic Cardiomyopathy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-12-18

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to explore if STI technology, especially TMAD, plays an important role in evaluating left ventricular longitudinal systolic function and discriminating SICM in patients with sepsis. The investigators also intend to prove that TMAD may have predictive value in patients with sepsis, which is worthy of in-depth study to find strong evidence-based medical evidence for subsequent clinical practical applications.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study on the Value of Three-dimensional Speckle Tracking Technique

NCT03905200

Echocardiography, Three-Dimensional Coronary Artery Disease

UNKNOWN

SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve

NCT06030596

Coronary Artery Disease

UNKNOWN

Morphological Predictors of Sudden Cardiac Death in Patients With Known Cardiomyopathies

NCT00312624

Cardiomyopathy

COMPLETED

Evaluation of Systemic Microvascular Endothelial Dysfunction in Patients Presenting With Infective Endocarditis

NCT02940340

Infective Endocarditis

COMPLETED

Risk Stratification Value of Biomarkers in Patients With Myocarditis

NCT06010199

Myocarditis

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In order to explore if STI technology, especially TMAD, plays an important role in evaluating left ventricular longitudinal systolic function and discriminating SICM in patients with sepsis, the investigators intend to explore that TMAD may have predictive value in patients with sepsis, which is worthy of in-depth study to find strong evidence-based medical evidence for subsequent clinical practical applications.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sepsis Cardiomyopathies Echocardiography

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients who are diagnosed as sepsis according to sepsis 3.0 criteria

Exclusion Criteria

* patients with history of organic heart disease;
* patients with history of heart failure
* holder of cardiac implanted device;
* patients with history of atrial fibrillation;
* refusal to participate in the study

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No